nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—esophageal cancer	0.464	0.729	CbGaD
Selegiline—ABCB1—esophageal cancer	0.173	0.271	CbGaD
Selegiline—CYP2C9—Capecitabine—esophageal cancer	0.0307	0.306	CbGbCtD
Selegiline—CYP2B6—Cisplatin—esophageal cancer	0.0293	0.292	CbGbCtD
Selegiline—CYP2C9—Cisplatin—esophageal cancer	0.0155	0.154	CbGbCtD
Selegiline—ABCB1—Cisplatin—esophageal cancer	0.015	0.15	CbGbCtD
Selegiline—ABCB1—Methotrexate—esophageal cancer	0.00975	0.0972	CbGbCtD
Selegiline—Benzyl alcohol—ALDH2—esophageal cancer	0.00105	0.756	CrCbGaD
Selegiline—Amphetamine—CYP2A6—esophageal cancer	0.000339	0.244	CrCbGaD
Selegiline—Bradycardia—Cisplatin—esophageal cancer	0.000299	0.00239	CcSEcCtD
Selegiline—Irritability—Capecitabine—esophageal cancer	0.000299	0.00239	CcSEcCtD
Selegiline—Cardiac arrest—Capecitabine—esophageal cancer	0.000298	0.00238	CcSEcCtD
Selegiline—Urinary retention—Capecitabine—esophageal cancer	0.000298	0.00238	CcSEcCtD
Selegiline—Mood swings—Capecitabine—esophageal cancer	0.000297	0.00237	CcSEcCtD
Selegiline—Ataxia—Capecitabine—esophageal cancer	0.000295	0.00235	CcSEcCtD
Selegiline—Coma—Methotrexate—esophageal cancer	0.000294	0.00235	CcSEcCtD
Selegiline—Dehydration—Capecitabine—esophageal cancer	0.000291	0.00233	CcSEcCtD
Selegiline—Ecchymosis—Methotrexate—esophageal cancer	0.00029	0.00232	CcSEcCtD
Selegiline—Urine output increased—Methotrexate—esophageal cancer	0.00029	0.00232	CcSEcCtD
Selegiline—Bladder pain—Methotrexate—esophageal cancer	0.00029	0.00232	CcSEcCtD
Selegiline—Neoplasm—Methotrexate—esophageal cancer	0.00029	0.00232	CcSEcCtD
Selegiline—Urinary tract disorder—Cisplatin—esophageal cancer	0.00029	0.00232	CcSEcCtD
Selegiline—Liver function test abnormal—Capecitabine—esophageal cancer	0.000289	0.00231	CcSEcCtD
Selegiline—Urethral disorder—Cisplatin—esophageal cancer	0.000288	0.0023	CcSEcCtD
Selegiline—Dry skin—Capecitabine—esophageal cancer	0.000287	0.0023	CcSEcCtD
Selegiline—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000286	0.00229	CcSEcCtD
Selegiline—Pulmonary oedema—Methotrexate—esophageal cancer	0.000286	0.00229	CcSEcCtD
Selegiline—Hypokalaemia—Capecitabine—esophageal cancer	0.000285	0.00228	CcSEcCtD
Selegiline—Visual impairment—Cisplatin—esophageal cancer	0.000283	0.00226	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000282	0.00226	CcSEcCtD
Selegiline—Gastritis—Capecitabine—esophageal cancer	0.000277	0.00222	CcSEcCtD
Selegiline—Muscular weakness—Capecitabine—esophageal cancer	0.000276	0.00221	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000276	0.00221	CcSEcCtD
Selegiline—Tinnitus—Cisplatin—esophageal cancer	0.000274	0.00219	CcSEcCtD
Selegiline—Lymphadenopathy—Methotrexate—esophageal cancer	0.000273	0.00218	CcSEcCtD
Selegiline—Flushing—Cisplatin—esophageal cancer	0.000273	0.00218	CcSEcCtD
Selegiline—Influenza—Capecitabine—esophageal cancer	0.000271	0.00216	CcSEcCtD
Selegiline—Dysphagia—Capecitabine—esophageal cancer	0.000271	0.00216	CcSEcCtD
Selegiline—Asthma—Capecitabine—esophageal cancer	0.000271	0.00216	CcSEcCtD
Selegiline—Diabetes mellitus—Methotrexate—esophageal cancer	0.000268	0.00214	CcSEcCtD
Selegiline—Photosensitivity—Methotrexate—esophageal cancer	0.000266	0.00212	CcSEcCtD
Selegiline—Polyuria—Methotrexate—esophageal cancer	0.000266	0.00212	CcSEcCtD
Selegiline—Sweating increased—Capecitabine—esophageal cancer	0.000264	0.00211	CcSEcCtD
Selegiline—Angina pectoris—Capecitabine—esophageal cancer	0.000264	0.00211	CcSEcCtD
Selegiline—Arrhythmia—Cisplatin—esophageal cancer	0.000263	0.0021	CcSEcCtD
Selegiline—Bronchitis—Capecitabine—esophageal cancer	0.00026	0.00208	CcSEcCtD
Selegiline—Alopecia—Cisplatin—esophageal cancer	0.00026	0.00208	CcSEcCtD
Selegiline—Erythema—Cisplatin—esophageal cancer	0.000256	0.00205	CcSEcCtD
Selegiline—Malnutrition—Cisplatin—esophageal cancer	0.000256	0.00205	CcSEcCtD
Selegiline—Dysuria—Capecitabine—esophageal cancer	0.000253	0.00202	CcSEcCtD
Selegiline—Flatulence—Cisplatin—esophageal cancer	0.000252	0.00202	CcSEcCtD
Selegiline—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000247	0.00198	CcSEcCtD
Selegiline—Weight increased—Capecitabine—esophageal cancer	0.000246	0.00197	CcSEcCtD
Selegiline—Muscle spasms—Cisplatin—esophageal cancer	0.000246	0.00197	CcSEcCtD
Selegiline—Weight decreased—Capecitabine—esophageal cancer	0.000245	0.00196	CcSEcCtD
Selegiline—Hyperglycaemia—Capecitabine—esophageal cancer	0.000244	0.00195	CcSEcCtD
Selegiline—Pneumonia—Capecitabine—esophageal cancer	0.000243	0.00194	CcSEcCtD
Selegiline—Vision blurred—Cisplatin—esophageal cancer	0.000241	0.00193	CcSEcCtD
Selegiline—Depression—Capecitabine—esophageal cancer	0.000241	0.00192	CcSEcCtD
Selegiline—Tremor—Cisplatin—esophageal cancer	0.00024	0.00192	CcSEcCtD
Selegiline—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000238	0.0019	CcSEcCtD
Selegiline—Lethargy—Methotrexate—esophageal cancer	0.000238	0.0019	CcSEcCtD
Selegiline—Ill-defined disorder—Cisplatin—esophageal cancer	0.000237	0.0019	CcSEcCtD
Selegiline—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000237	0.00189	CcSEcCtD
Selegiline—Myocardial infarction—Capecitabine—esophageal cancer	0.000237	0.00189	CcSEcCtD
Selegiline—Anaemia—Cisplatin—esophageal cancer	0.000237	0.00189	CcSEcCtD
Selegiline—Stomatitis—Capecitabine—esophageal cancer	0.000235	0.00188	CcSEcCtD
Selegiline—Conjunctivitis—Capecitabine—esophageal cancer	0.000235	0.00188	CcSEcCtD
Selegiline—Urinary tract infection—Capecitabine—esophageal cancer	0.000235	0.00188	CcSEcCtD
Selegiline—Osteoarthritis—Methotrexate—esophageal cancer	0.000233	0.00186	CcSEcCtD
Selegiline—Malaise—Cisplatin—esophageal cancer	0.000231	0.00184	CcSEcCtD
Selegiline—Haematuria—Capecitabine—esophageal cancer	0.00023	0.00184	CcSEcCtD
Selegiline—Leukopenia—Cisplatin—esophageal cancer	0.000229	0.00183	CcSEcCtD
Selegiline—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000228	0.00183	CcSEcCtD
Selegiline—Epistaxis—Capecitabine—esophageal cancer	0.000228	0.00182	CcSEcCtD
Selegiline—Irritability—Methotrexate—esophageal cancer	0.000223	0.00178	CcSEcCtD
Selegiline—Convulsion—Cisplatin—esophageal cancer	0.000222	0.00177	CcSEcCtD
Selegiline—Mood swings—Methotrexate—esophageal cancer	0.000221	0.00177	CcSEcCtD
Selegiline—Bradycardia—Capecitabine—esophageal cancer	0.000221	0.00176	CcSEcCtD
Selegiline—Ataxia—Methotrexate—esophageal cancer	0.000219	0.00175	CcSEcCtD
Selegiline—Myalgia—Cisplatin—esophageal cancer	0.000218	0.00174	CcSEcCtD
Selegiline—Rhinitis—Capecitabine—esophageal cancer	0.000217	0.00174	CcSEcCtD
Selegiline—Anxiety—Cisplatin—esophageal cancer	0.000217	0.00174	CcSEcCtD
Selegiline—Hepatitis—Capecitabine—esophageal cancer	0.000217	0.00173	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000216	0.00173	CcSEcCtD
Selegiline—Hypoaesthesia—Capecitabine—esophageal cancer	0.000216	0.00172	CcSEcCtD
Selegiline—Liver function test abnormal—Methotrexate—esophageal cancer	0.000215	0.00172	CcSEcCtD
Selegiline—Discomfort—Cisplatin—esophageal cancer	0.000215	0.00172	CcSEcCtD
Selegiline—Pharyngitis—Capecitabine—esophageal cancer	0.000215	0.00172	CcSEcCtD
Selegiline—Urinary tract disorder—Capecitabine—esophageal cancer	0.000214	0.00171	CcSEcCtD
Selegiline—Oedema peripheral—Capecitabine—esophageal cancer	0.000213	0.00171	CcSEcCtD
Selegiline—Urethral disorder—Capecitabine—esophageal cancer	0.000212	0.0017	CcSEcCtD
Selegiline—Oedema—Cisplatin—esophageal cancer	0.000209	0.00167	CcSEcCtD
Selegiline—Visual impairment—Capecitabine—esophageal cancer	0.000209	0.00167	CcSEcCtD
Selegiline—Infection—Cisplatin—esophageal cancer	0.000207	0.00166	CcSEcCtD
Selegiline—Nervous system disorder—Cisplatin—esophageal cancer	0.000205	0.00164	CcSEcCtD
Selegiline—Thrombocytopenia—Cisplatin—esophageal cancer	0.000204	0.00163	CcSEcCtD
Selegiline—Tachycardia—Cisplatin—esophageal cancer	0.000204	0.00163	CcSEcCtD
Selegiline—Skin disorder—Cisplatin—esophageal cancer	0.000203	0.00162	CcSEcCtD
Selegiline—Tinnitus—Capecitabine—esophageal cancer	0.000202	0.00162	CcSEcCtD
Selegiline—Hyperhidrosis—Cisplatin—esophageal cancer	0.000202	0.00161	CcSEcCtD
Selegiline—Asthma—Methotrexate—esophageal cancer	0.000202	0.00161	CcSEcCtD
Selegiline—Flushing—Capecitabine—esophageal cancer	0.000201	0.00161	CcSEcCtD
Selegiline—Eosinophilia—Methotrexate—esophageal cancer	0.0002	0.0016	CcSEcCtD
Selegiline—Anorexia—Cisplatin—esophageal cancer	0.000199	0.00159	CcSEcCtD
Selegiline—Angiopathy—Capecitabine—esophageal cancer	0.000197	0.00157	CcSEcCtD
Selegiline—Hypotension—Cisplatin—esophageal cancer	0.000195	0.00156	CcSEcCtD
Selegiline—Chills—Capecitabine—esophageal cancer	0.000194	0.00155	CcSEcCtD
Selegiline—Arrhythmia—Capecitabine—esophageal cancer	0.000194	0.00155	CcSEcCtD
Selegiline—Alopecia—Capecitabine—esophageal cancer	0.000191	0.00153	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00019	0.00152	CcSEcCtD
Selegiline—Mental disorder—Capecitabine—esophageal cancer	0.00019	0.00152	CcSEcCtD
Selegiline—Malnutrition—Capecitabine—esophageal cancer	0.000189	0.00151	CcSEcCtD
Selegiline—Erythema—Capecitabine—esophageal cancer	0.000189	0.00151	CcSEcCtD
Selegiline—Dysuria—Methotrexate—esophageal cancer	0.000188	0.00151	CcSEcCtD
Selegiline—Paraesthesia—Cisplatin—esophageal cancer	0.000188	0.0015	CcSEcCtD
Selegiline—Dyspnoea—Cisplatin—esophageal cancer	0.000186	0.00149	CcSEcCtD
Selegiline—Flatulence—Capecitabine—esophageal cancer	0.000186	0.00149	CcSEcCtD
Selegiline—Erectile dysfunction—Methotrexate—esophageal cancer	0.000186	0.00148	CcSEcCtD
Selegiline—Dysgeusia—Capecitabine—esophageal cancer	0.000185	0.00148	CcSEcCtD
Selegiline—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000184	0.00147	CcSEcCtD
Selegiline—Back pain—Capecitabine—esophageal cancer	0.000182	0.00146	CcSEcCtD
Selegiline—Decreased appetite—Cisplatin—esophageal cancer	0.000182	0.00145	CcSEcCtD
Selegiline—Muscle spasms—Capecitabine—esophageal cancer	0.000181	0.00145	CcSEcCtD
Selegiline—Pneumonia—Methotrexate—esophageal cancer	0.000181	0.00144	CcSEcCtD
Selegiline—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00018	0.00144	CcSEcCtD
Selegiline—Drowsiness—Methotrexate—esophageal cancer	0.00018	0.00144	CcSEcCtD
Selegiline—Depression—Methotrexate—esophageal cancer	0.000179	0.00143	CcSEcCtD
Selegiline—Pain—Cisplatin—esophageal cancer	0.000179	0.00143	CcSEcCtD
Selegiline—Vision blurred—Capecitabine—esophageal cancer	0.000178	0.00142	CcSEcCtD
Selegiline—Tremor—Capecitabine—esophageal cancer	0.000177	0.00141	CcSEcCtD
Selegiline—Stomatitis—Methotrexate—esophageal cancer	0.000175	0.0014	CcSEcCtD
Selegiline—Ill-defined disorder—Capecitabine—esophageal cancer	0.000175	0.0014	CcSEcCtD
Selegiline—Conjunctivitis—Methotrexate—esophageal cancer	0.000175	0.0014	CcSEcCtD
Selegiline—Anaemia—Capecitabine—esophageal cancer	0.000174	0.00139	CcSEcCtD
Selegiline—Sweating—Methotrexate—esophageal cancer	0.000172	0.00138	CcSEcCtD
Selegiline—Feeling abnormal—Cisplatin—esophageal cancer	0.000172	0.00138	CcSEcCtD
Selegiline—Haematuria—Methotrexate—esophageal cancer	0.000171	0.00137	CcSEcCtD
Selegiline—Malaise—Capecitabine—esophageal cancer	0.00017	0.00136	CcSEcCtD
Selegiline—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00017	0.00136	CcSEcCtD
Selegiline—Epistaxis—Methotrexate—esophageal cancer	0.000169	0.00136	CcSEcCtD
Selegiline—Vertigo—Capecitabine—esophageal cancer	0.000169	0.00135	CcSEcCtD
Selegiline—Syncope—Capecitabine—esophageal cancer	0.000169	0.00135	CcSEcCtD
Selegiline—Leukopenia—Capecitabine—esophageal cancer	0.000169	0.00135	CcSEcCtD
Selegiline—Palpitations—Capecitabine—esophageal cancer	0.000167	0.00133	CcSEcCtD
Selegiline—Loss of consciousness—Capecitabine—esophageal cancer	0.000166	0.00133	CcSEcCtD
Selegiline—Body temperature increased—Cisplatin—esophageal cancer	0.000165	0.00132	CcSEcCtD
Selegiline—Cough—Capecitabine—esophageal cancer	0.000165	0.00132	CcSEcCtD
Selegiline—Hypertension—Capecitabine—esophageal cancer	0.000163	0.0013	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—esophageal cancer	0.000161	0.00129	CcSEcCtD
Selegiline—Arthralgia—Capecitabine—esophageal cancer	0.000161	0.00128	CcSEcCtD
Selegiline—Chest pain—Capecitabine—esophageal cancer	0.000161	0.00128	CcSEcCtD
Selegiline—Myalgia—Capecitabine—esophageal cancer	0.000161	0.00128	CcSEcCtD
Selegiline—Pharyngitis—Methotrexate—esophageal cancer	0.00016	0.00128	CcSEcCtD
Selegiline—Anxiety—Capecitabine—esophageal cancer	0.00016	0.00128	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000159	0.00128	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—esophageal cancer	0.000159	0.00127	CcSEcCtD
Selegiline—Discomfort—Capecitabine—esophageal cancer	0.000159	0.00127	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—esophageal cancer	0.000158	0.00126	CcSEcCtD
Selegiline—Dry mouth—Capecitabine—esophageal cancer	0.000157	0.00126	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—esophageal cancer	0.000155	0.00124	CcSEcCtD
Selegiline—Confusional state—Capecitabine—esophageal cancer	0.000155	0.00124	CcSEcCtD
Selegiline—Oedema—Capecitabine—esophageal cancer	0.000154	0.00123	CcSEcCtD
Selegiline—Hypersensitivity—Cisplatin—esophageal cancer	0.000154	0.00123	CcSEcCtD
Selegiline—Infection—Capecitabine—esophageal cancer	0.000153	0.00122	CcSEcCtD
Selegiline—Shock—Capecitabine—esophageal cancer	0.000151	0.00121	CcSEcCtD
Selegiline—Nervous system disorder—Capecitabine—esophageal cancer	0.000151	0.00121	CcSEcCtD
Selegiline—Thrombocytopenia—Capecitabine—esophageal cancer	0.000151	0.00121	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—esophageal cancer	0.00015	0.0012	CcSEcCtD
Selegiline—Tachycardia—Capecitabine—esophageal cancer	0.00015	0.0012	CcSEcCtD
Selegiline—Asthenia—Cisplatin—esophageal cancer	0.00015	0.0012	CcSEcCtD
Selegiline—Skin disorder—Capecitabine—esophageal cancer	0.00015	0.0012	CcSEcCtD
Selegiline—Hyperhidrosis—Capecitabine—esophageal cancer	0.000149	0.00119	CcSEcCtD
Selegiline—Anorexia—Capecitabine—esophageal cancer	0.000147	0.00117	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—esophageal cancer	0.000146	0.00117	CcSEcCtD
Selegiline—Chills—Methotrexate—esophageal cancer	0.000145	0.00116	CcSEcCtD
Selegiline—Hypotension—Capecitabine—esophageal cancer	0.000144	0.00115	CcSEcCtD
Selegiline—Diarrhoea—Cisplatin—esophageal cancer	0.000143	0.00114	CcSEcCtD
Selegiline—Alopecia—Methotrexate—esophageal cancer	0.000143	0.00114	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—esophageal cancer	0.000141	0.00113	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—esophageal cancer	0.00014	0.00112	CcSEcCtD
Selegiline—Erythema—Methotrexate—esophageal cancer	0.00014	0.00112	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00014	0.00112	CcSEcCtD
Selegiline—Insomnia—Capecitabine—esophageal cancer	0.000139	0.00111	CcSEcCtD
Selegiline—Paraesthesia—Capecitabine—esophageal cancer	0.000138	0.00111	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—esophageal cancer	0.000138	0.0011	CcSEcCtD
Selegiline—Dyspnoea—Capecitabine—esophageal cancer	0.000137	0.0011	CcSEcCtD
Selegiline—Back pain—Methotrexate—esophageal cancer	0.000136	0.00109	CcSEcCtD
Selegiline—Dyspepsia—Capecitabine—esophageal cancer	0.000136	0.00108	CcSEcCtD
Selegiline—Decreased appetite—Capecitabine—esophageal cancer	0.000134	0.00107	CcSEcCtD
Selegiline—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000133	0.00106	CcSEcCtD
Selegiline—Vomiting—Cisplatin—esophageal cancer	0.000133	0.00106	CcSEcCtD
Selegiline—Fatigue—Capecitabine—esophageal cancer	0.000133	0.00106	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—esophageal cancer	0.000132	0.00106	CcSEcCtD
Selegiline—Rash—Cisplatin—esophageal cancer	0.000132	0.00105	CcSEcCtD
Selegiline—Pain—Capecitabine—esophageal cancer	0.000132	0.00105	CcSEcCtD
Selegiline—Constipation—Capecitabine—esophageal cancer	0.000132	0.00105	CcSEcCtD
Selegiline—Dermatitis—Cisplatin—esophageal cancer	0.000132	0.00105	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—esophageal cancer	0.00013	0.00104	CcSEcCtD
Selegiline—Anaemia—Methotrexate—esophageal cancer	0.00013	0.00104	CcSEcCtD
Selegiline—Feeling abnormal—Capecitabine—esophageal cancer	0.000127	0.00101	CcSEcCtD
Selegiline—Malaise—Methotrexate—esophageal cancer	0.000127	0.00101	CcSEcCtD
Selegiline—Vertigo—Methotrexate—esophageal cancer	0.000126	0.00101	CcSEcCtD
Selegiline—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000126	0.00101	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—esophageal cancer	0.000126	0.001	CcSEcCtD
Selegiline—Nausea—Cisplatin—esophageal cancer	0.000124	0.000992	CcSEcCtD
Selegiline—Cough—Methotrexate—esophageal cancer	0.000123	0.00098	CcSEcCtD
Selegiline—Urticaria—Capecitabine—esophageal cancer	0.000122	0.000978	CcSEcCtD
Selegiline—Abdominal pain—Capecitabine—esophageal cancer	0.000122	0.000973	CcSEcCtD
Selegiline—Body temperature increased—Capecitabine—esophageal cancer	0.000122	0.000973	CcSEcCtD
Selegiline—Convulsion—Methotrexate—esophageal cancer	0.000122	0.000973	CcSEcCtD
Selegiline—Chest pain—Methotrexate—esophageal cancer	0.00012	0.000956	CcSEcCtD
Selegiline—Myalgia—Methotrexate—esophageal cancer	0.00012	0.000956	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—esophageal cancer	0.00012	0.000956	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000119	0.000949	CcSEcCtD
Selegiline—Discomfort—Methotrexate—esophageal cancer	0.000118	0.000944	CcSEcCtD
Selegiline—Confusional state—Methotrexate—esophageal cancer	0.000116	0.000924	CcSEcCtD
Selegiline—Infection—Methotrexate—esophageal cancer	0.000114	0.00091	CcSEcCtD
Selegiline—Hypersensitivity—Capecitabine—esophageal cancer	0.000113	0.000907	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—esophageal cancer	0.000112	0.000899	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—esophageal cancer	0.000112	0.000897	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—esophageal cancer	0.000111	0.00089	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—esophageal cancer	0.000111	0.000886	CcSEcCtD
Selegiline—Asthenia—Capecitabine—esophageal cancer	0.00011	0.000883	CcSEcCtD
Selegiline—Anorexia—Methotrexate—esophageal cancer	0.000109	0.000873	CcSEcCtD
Selegiline—Pruritus—Capecitabine—esophageal cancer	0.000109	0.000871	CcSEcCtD
Selegiline—Hypotension—Methotrexate—esophageal cancer	0.000107	0.000856	CcSEcCtD
Selegiline—Diarrhoea—Capecitabine—esophageal cancer	0.000105	0.000842	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000104	0.000835	CcSEcCtD
Selegiline—Insomnia—Methotrexate—esophageal cancer	0.000104	0.000829	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—esophageal cancer	0.000103	0.000823	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—esophageal cancer	0.000102	0.000817	CcSEcCtD
Selegiline—Somnolence—Methotrexate—esophageal cancer	0.000102	0.000815	CcSEcCtD
Selegiline—Dizziness—Capecitabine—esophageal cancer	0.000102	0.000814	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—esophageal cancer	0.000101	0.000807	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—esophageal cancer	9.96e-05	0.000796	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—esophageal cancer	9.89e-05	0.000791	CcSEcCtD
Selegiline—Fatigue—Methotrexate—esophageal cancer	9.88e-05	0.00079	CcSEcCtD
Selegiline—Pain—Methotrexate—esophageal cancer	9.8e-05	0.000784	CcSEcCtD
Selegiline—Vomiting—Capecitabine—esophageal cancer	9.79e-05	0.000783	CcSEcCtD
Selegiline—Rash—Capecitabine—esophageal cancer	9.71e-05	0.000776	CcSEcCtD
Selegiline—Dermatitis—Capecitabine—esophageal cancer	9.7e-05	0.000775	CcSEcCtD
Selegiline—Headache—Capecitabine—esophageal cancer	9.64e-05	0.000771	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—esophageal cancer	9.44e-05	0.000755	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—esophageal cancer	9.37e-05	0.000749	CcSEcCtD
Selegiline—Nausea—Capecitabine—esophageal cancer	9.14e-05	0.000731	CcSEcCtD
Selegiline—Urticaria—Methotrexate—esophageal cancer	9.1e-05	0.000728	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—esophageal cancer	9.06e-05	0.000724	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—esophageal cancer	9.06e-05	0.000724	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—esophageal cancer	8.44e-05	0.000675	CcSEcCtD
Selegiline—Asthenia—Methotrexate—esophageal cancer	8.22e-05	0.000657	CcSEcCtD
Selegiline—Pruritus—Methotrexate—esophageal cancer	8.11e-05	0.000648	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—esophageal cancer	7.84e-05	0.000627	CcSEcCtD
Selegiline—Dizziness—Methotrexate—esophageal cancer	7.58e-05	0.000606	CcSEcCtD
Selegiline—Vomiting—Methotrexate—esophageal cancer	7.29e-05	0.000583	CcSEcCtD
Selegiline—Rash—Methotrexate—esophageal cancer	7.23e-05	0.000578	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—esophageal cancer	7.22e-05	0.000577	CcSEcCtD
Selegiline—Headache—Methotrexate—esophageal cancer	7.18e-05	0.000574	CcSEcCtD
Selegiline—Nausea—Methotrexate—esophageal cancer	6.81e-05	0.000544	CcSEcCtD
Selegiline—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ABCB1—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.67e-05	0.000123	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.66e-05	0.000121	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.65e-05	0.000121	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALDH2—esophageal cancer	1.64e-05	0.000121	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.64e-05	0.00012	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.63e-05	0.00012	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.63e-05	0.00012	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.61e-05	0.000118	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.61e-05	0.000118	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.6e-05	0.000117	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ADH7—esophageal cancer	1.6e-05	0.000117	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.6e-05	0.000117	CbGpPWpGaD
Selegiline—MAOB—Metabolism—NOS3—esophageal cancer	1.6e-05	0.000117	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.59e-05	0.000117	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALOX15—esophageal cancer	1.59e-05	0.000117	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TYMP—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.58e-05	0.000116	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TYMP—esophageal cancer	1.57e-05	0.000115	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTT1—esophageal cancer	1.56e-05	0.000115	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TPI1—esophageal cancer	1.56e-05	0.000114	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.56e-05	0.000114	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP2A6—esophageal cancer	1.55e-05	0.000113	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.54e-05	0.000113	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.53e-05	0.000112	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTO1—esophageal cancer	1.52e-05	0.000111	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TPI1—esophageal cancer	1.52e-05	0.000111	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GNG7—esophageal cancer	1.52e-05	0.000111	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.5e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.5e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ENO1—esophageal cancer	1.5e-05	0.00011	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.49e-05	0.000109	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.49e-05	0.000109	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.48e-05	0.000109	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PSME2—esophageal cancer	1.47e-05	0.000108	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PSME1—esophageal cancer	1.47e-05	0.000108	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ENO1—esophageal cancer	1.47e-05	0.000107	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS1—esophageal cancer	1.47e-05	0.000107	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTGS2—esophageal cancer	1.46e-05	0.000107	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALDOB—esophageal cancer	1.46e-05	0.000107	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CA1—esophageal cancer	1.45e-05	0.000106	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.45e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PSME2—esophageal cancer	1.44e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PSME1—esophageal cancer	1.44e-05	0.000106	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.44e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.43e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TPI1—esophageal cancer	1.43e-05	0.000105	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.42e-05	0.000104	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.42e-05	0.000104	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TPI1—esophageal cancer	1.42e-05	0.000104	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.42e-05	0.000104	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.4e-05	0.000103	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GAPDH—esophageal cancer	1.4e-05	0.000103	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.4e-05	0.000103	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CRABP1—esophageal cancer	1.39e-05	0.000102	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.37e-05	0.000101	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.36e-05	9.97e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GNG7—esophageal cancer	1.35e-05	9.92e-05	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.35e-05	9.92e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.35e-05	9.92e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.35e-05	9.91e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TYMP—esophageal cancer	1.34e-05	9.83e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.34e-05	9.8e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.33e-05	9.76e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CA2—esophageal cancer	1.33e-05	9.74e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GNG7—esophageal cancer	1.32e-05	9.69e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.32e-05	9.68e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.31e-05	9.6e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.31e-05	9.6e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.3e-05	9.56e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.3e-05	9.52e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.3e-05	9.51e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.27e-05	9.33e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.27e-05	9.32e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.27e-05	9.3e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ENO1—esophageal cancer	1.27e-05	9.29e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.27e-05	9.29e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PSME1—esophageal cancer	1.25e-05	9.15e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PSME2—esophageal cancer	1.25e-05	9.15e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP1B1—esophageal cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GNG7—esophageal cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALDH2—esophageal cancer	1.24e-05	9.08e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ADH7—esophageal cancer	1.23e-05	9.05e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.23e-05	9.05e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GNG7—esophageal cancer	1.23e-05	9.05e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—EP300—esophageal cancer	1.21e-05	8.89e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.21e-05	8.89e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TPI1—esophageal cancer	1.21e-05	8.89e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.21e-05	8.85e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.2e-05	8.77e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.19e-05	8.74e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.19e-05	8.71e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTT1—esophageal cancer	1.18e-05	8.63e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP19A1—esophageal cancer	1.17e-05	8.59e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.17e-05	8.55e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.16e-05	8.53e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.16e-05	8.52e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.16e-05	8.48e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ENO1—esophageal cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.12e-05	8.2e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CREBBP—esophageal cancer	1.12e-05	8.19e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PSME2—esophageal cancer	1.11e-05	8.17e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PSME1—esophageal cancer	1.11e-05	8.17e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.11e-05	8.14e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.11e-05	8.13e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ENO1—esophageal cancer	1.1e-05	8.09e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS1—esophageal cancer	1.1e-05	8.09e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.1e-05	8.08e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.1e-05	8.07e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.1e-05	8.04e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.09e-05	8e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.09e-05	7.99e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PSME2—esophageal cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PSME1—esophageal cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.08e-05	7.94e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.08e-05	7.9e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—HMOX1—esophageal cancer	1.07e-05	7.84e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GNG7—esophageal cancer	1.05e-05	7.73e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.05e-05	7.68e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ENO1—esophageal cancer	1.04e-05	7.62e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.04e-05	7.62e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TYMP—esophageal cancer	1.03e-05	7.59e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.03e-05	7.56e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ENO1—esophageal cancer	1.03e-05	7.56e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ABCB1—esophageal cancer	1.03e-05	7.52e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PSME1—esophageal cancer	1.02e-05	7.51e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PSME2—esophageal cancer	1.02e-05	7.51e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PSME2—esophageal cancer	1.02e-05	7.45e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PSME1—esophageal cancer	1.02e-05	7.45e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.01e-05	7.42e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—NOS3—esophageal cancer	1e-05	7.34e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALDH2—esophageal cancer	9.88e-06	7.25e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.81e-06	7.19e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.73e-06	7.13e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1B1—esophageal cancer	9.61e-06	7.05e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.4e-06	6.89e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.38e-06	6.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.36e-06	6.86e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TPI1—esophageal cancer	9.36e-06	6.86e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.29e-06	6.81e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.26e-06	6.79e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.24e-06	6.77e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—esophageal cancer	9.15e-06	6.71e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.07e-06	6.65e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP19A1—esophageal cancer	9.04e-06	6.63e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—esophageal cancer	8.98e-06	6.58e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.97e-06	6.58e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.87e-06	6.5e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.87e-06	6.5e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1B1—esophageal cancer	8.84e-06	6.48e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.82e-06	6.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO1—esophageal cancer	8.81e-06	6.46e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS1—esophageal cancer	8.81e-06	6.46e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1B1—esophageal cancer	8.77e-06	6.43e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PSME1—esophageal cancer	8.68e-06	6.36e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PSME2—esophageal cancer	8.68e-06	6.36e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CREBBP—esophageal cancer	8.68e-06	6.36e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.64e-06	6.33e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.56e-06	6.27e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP19A1—esophageal cancer	8.31e-06	6.09e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—HMOX1—esophageal cancer	8.25e-06	6.05e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.24e-06	6.04e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GNG7—esophageal cancer	8.14e-06	5.97e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.09e-06	5.93e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—HMOX1—esophageal cancer	8.05e-06	5.9e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ABCB1—esophageal cancer	7.92e-06	5.8e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—NOS3—esophageal cancer	7.77e-06	5.7e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.63e-06	5.59e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—EP300—esophageal cancer	7.61e-06	5.58e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HMOX1—esophageal cancer	7.59e-06	5.56e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.58e-06	5.56e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.52e-06	5.51e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.49e-06	5.49e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.38e-06	5.41e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ABCB1—esophageal cancer	7.28e-06	5.34e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.26e-06	5.32e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.22e-06	5.29e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7.17e-06	5.26e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—esophageal cancer	7.11e-06	5.21e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.04e-06	5.16e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CREBBP—esophageal cancer	7e-06	5.13e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CREBBP—esophageal cancer	6.86e-06	5.03e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO1—esophageal cancer	6.8e-06	4.98e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.8e-06	4.98e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.71e-06	4.92e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PSME2—esophageal cancer	6.7e-06	4.91e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PSME1—esophageal cancer	6.7e-06	4.91e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.43e-06	4.71e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.31e-06	4.62e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NOS3—esophageal cancer	6.27e-06	4.6e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.17e-06	4.52e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NOS3—esophageal cancer	6.14e-06	4.5e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.99e-06	4.39e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.93e-06	4.35e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—EP300—esophageal cancer	5.91e-06	4.33e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.78e-06	4.24e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—esophageal cancer	5.73e-06	4.2e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—esophageal cancer	5.63e-06	4.13e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—esophageal cancer	5.62e-06	4.12e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.46e-06	4e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.44e-06	3.98e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NOS3—esophageal cancer	5.31e-06	3.89e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.29e-06	3.88e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CREBBP—esophageal cancer	5.16e-06	3.79e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.96e-06	3.64e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.87e-06	3.57e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.85e-06	3.56e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.82e-06	3.54e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—EP300—esophageal cancer	4.77e-06	3.5e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.76e-06	3.49e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NOS3—esophageal cancer	4.74e-06	3.47e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—EP300—esophageal cancer	4.67e-06	3.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.66e-06	3.42e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NOS3—esophageal cancer	4.62e-06	3.39e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—esophageal cancer	4.37e-06	3.21e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NOS3—esophageal cancer	4.36e-06	3.19e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.33e-06	3.18e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NOS3—esophageal cancer	4.32e-06	3.17e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—esophageal cancer	4.23e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.12e-06	3.02e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—EP300—esophageal cancer	4.04e-06	2.96e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.99e-06	2.92e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.95e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NOS3—esophageal cancer	3.69e-06	2.71e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—EP300—esophageal cancer	3.6e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—esophageal cancer	3.53e-06	2.59e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—EP300—esophageal cancer	3.52e-06	2.58e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—esophageal cancer	3.46e-06	2.53e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.38e-06	2.47e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—EP300—esophageal cancer	3.31e-06	2.43e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—EP300—esophageal cancer	3.29e-06	2.41e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.18e-06	2.33e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.99e-06	2.19e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NOS3—esophageal cancer	2.85e-06	2.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—EP300—esophageal cancer	2.81e-06	2.06e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.67e-06	1.95e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.61e-06	1.91e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.6e-06	1.91e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.45e-06	1.8e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.43e-06	1.78e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—EP300—esophageal cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.08e-06	1.52e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.6e-06	1.18e-05	CbGpPWpGaD
